BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9816161)

  • 1. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
    Sinicrope FA; Evans DB; Leach SD; Cleary KR; Fenoglio CJ; Lee JJ; Abbruzzese JL
    Clin Cancer Res; 1996 Dec; 2(12):2015-22. PubMed ID: 9816161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
    Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
    Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
    Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
    J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
    Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
    In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS; Waelchli L; Bründler MA
    Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
    Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
    Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.